Editorial

March 31, 2024


JUO, the Journal of Urologic Oncology, Celebrates Its Second Anniversary
Cheol Kwak
J Urol Oncol. 2024;22(1):1-3.

Invited Review

March 31, 2024


Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Chang Wook Jeong
J Urol Oncol. 2024;22(1):4-10.

Invited Review

March 31, 2024


Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review
Minseok Suh, Gi Jeong Cheon
J Urol Oncol. 2024;22(1):11-20.

Original Article

March 31, 2024


High-Grade Late Urinary Toxicity Following Salvage Radiotherapy After Radical Prostatectomy: A Retrospective Cohort Study
Seung-Kwon Choi, Myong Kim, Sang Mi Lee, et al.
J Urol Oncol. 2024;22(1):21-28.

Original Article

March 31, 2024


Enzalutamide Maintenance Following Docetaxel in Metastatic Castration-Naive Prostate Cancer: A Pilot Feasibility Study
Sung Hee Lim, Sung Wook Cho, Jae Hoon Chung, et al.
J Urol Oncol. 2024;22(1):29-33.

Systemic Review and Meta-analysis

March 31, 2024


Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis
Hui Mo Gu, Seung Il Jung, Dongdeuk Kwon, et al.
J Urol Oncol. 2024;22(1):34-41.

Original Article

March 31, 2024


Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis
Jung Hoon Kim, Ji Woong Hwang
J Urol Oncol. 2024;22(1):42-51.

Original Article

March 31, 2024


Prognostic Factors and Cancer-Specific Survival of Surgically Managed Renal Cell Carcinoma With Venous Thrombus: A 30-Year Experience at a Tertiary Referral Center
Hyun Young Lee, Yunjoong Kim, Bumjin Lim, et al.
J Urol Oncol. 2024;22(1):52-58.

Original Article

March 31, 2024


Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study
Joohyun Hong, Ghee Young Kwon, Minyong Kang, et al.
J Urol Oncol. 2024;22(1):59-67.

Invited Review

March 31, 2024


Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma
Sung Han Kim, Ilma S. Savul, Seth P. Lerner
J Urol Oncol. 2024;22(1):68-77.

Systemic Review and Meta-analysis

March 31, 2024


Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients
Stefani Frost, Parisa Ziarati, Ryan Moen, et al.
J Urol Oncol. 2024;22(1):78-94.

Erratum

March 31, 2024


Declaration of Conflict of Interest for Editorial Board Members’ Articles
J Urol Oncol. 2024;22(1):95-96.
New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer  (4,249 times)
Jaewoon Jeong, Jae Baek Ha, In Ho Chang
Korean J Urol Oncol. 2022;20(1):12-24.

Review Article

Feb 24, 2022

The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer  (3,940 times)
Jae Young Joung, Sung Han Kim
Korean J Urol Oncol. 2022;20(1):1-11.

Review Article

Feb 24, 2022

The Present and Future of Intravesical Therapy in Bladder Cancer  (3,549 times)
Sin-Woo Seong, Youngjae Shin, In Ho Chang, et al.
Korean J Urol Oncol. 2022;20(2):82-91.

Review Article

May 26, 2022

Trends of First-Line Targeted Therapy in Korean Patients With Metastatic Clear Cell Renal Cell Carcinoma: Sunitinib Versus Pazopanib, a Multicenter Study  (3,172 times)
Minsu Choi, Teak Jun Shin, Byung Hoon Kim, et al.
Korean J Urol Oncol. 2022;20(2):115-122.

Original Article

May 26, 2022

Is Cytoreductive Nephrectomy Still Beneficial for Patients With Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era?  (2,980 times)
Jae Duck Choi, Jeong Man Cho, Tag Keun Yoo
Korean J Urol Oncol. 2022;20(3):139-150.

Review Article

Aug 25, 2022

Complex Epidemiology of Prostate Cancer in Asian Countries  (2,862 times)
Kagenori Ito, Takahiro Kimura
J Urol Oncol. 2023;21(1):5-13.

Reivew Article

Mar 31, 2023

An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer  (2,843 times)
Jeong Hee Hong
Korean J Urol Oncol. 2022;20(4):207-222.

Review Article

Nov 30, 2022

2021 Consensus Statements on the Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma From the Korean Renal Cancer Study Group (KRoCS)  (2,762 times)
Chan Ho Lee, Minyong Kang, Cheol Kwak, et al.
Korean J Urol Oncol. 2022;20(3):151-162.

Review Article

Aug 25, 2022

Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer  (2,690 times)
Ja Yoon Ku, Eu Chang Hwang, Chan Ho Lee, et al.
Korean J Urol Oncol. 2022;20(1):52-58.Correction in: J Urol Oncol 2023;21(3):277

Original Article

Feb 24, 2022

Clinical Utility of Combining Prostate Health Index and PI-RADS Version 2 to Improve Detection of Clinically Significant Prostate Cancer  (2,600 times)
Wan Song, Chung Un Lee, Jae Hoon Chung, et al.
Korean J Urol Oncol. 2022;20(2):107-114.

Original Article

May 26, 2022

Artificial Intelligence on Urology Lab  (2,593 times)
Jae Baek Ha, Jaewoon Jeong, Jeongyoon Suh, et al.
Korean J Urol Oncol. 2022;20(3):163-176.

Review Article

Aug 25, 2022

Enhanced Recovery After Surgery Program for Radical Cystectomy  (2,567 times)
Whi-An Kwon, Ho Kyung Seo
Korean J Urol Oncol. 2022;20(2):92-106.

Review Article

May 26, 2022

Update of the Diagnostic and Therapeutic Role of the Pelvic Lymph Node Dissection Boundaries During Radical Cystectomy in Muscle Invasive Bladder Cancer  (2,538 times)
Whi-An Kwon, Ho Kyung Seo
Korean J Urol Oncol. 2022;20(2):71-81.

Review Article

May 26, 2022

The Incidence of Prostate-Specific Antigen Test in a Country With a Limited Social Perception of Prostate Cancer 2006-2016: Disparities Manifested by Residential Area  (2,533 times)
Young Hwii Ko, Byung Hoon Kim
Korean J Urol Oncol. 2022;20(1):43-51.

Original Article

Feb 24, 2022

Comparison of Perioperative and Oncologic Outcome Between Old Versus Oldest Old After Radical Cystectomy for Bladder Cancer  (2,503 times)
Sang Soo Park, Chung Un Lee, Jae Hoon Chung, et al.
Korean J Urol Oncol. 2022;20(3):186-196.

Original Article

Aug 25, 2022

Prostate-Specific Antigen Variation as a Predictor of Prostate Cancer in Patients With Prostate-Specific Antigen ≤20 ng/mL Who Underwent Magnetic Resonance Imaging-Targeted Prostate Biopsy  (2,448 times)
Tae Hyun Hwang, Kwang Suk Lee, Kyo Chul Koo, et al.
Korean J Urol Oncol. 2022;20(2):123-132.

Original Article

May 26, 2022

A Survey on the Quality of Life of Prostate Cancer Patients in Korean Prostate Cancer Patients Association  (2,419 times)
Yun-Sok Ha, Kwang Taek Kim, Wook Nam, et al.
Korean J Urol Oncol. 2022;20(4):265-272.

Original Article

Nov 30, 2022

De Ritis Ratio, Neutrophil-to-Lymphocyte Ratio, and Albumin Are Significant Prognostic Factors for Survival Even After Adjusted by the Treatment Duration in Metastatic Kidney and Bladder Cancer Treated With Immune-Checkpoint Inhibitors  (2,206 times)
Sung Han Kim, Eun Young Park, Hyung-Ho Lee, et al.
Korean J Urol Oncol. 2022;20(1):25-33.

Original Article

Feb 24, 2022

Current Update on Prostate Cancer Immunotherapy  (2,197 times)
Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim
J Urol Oncol. 2023;21(1):14-22.

Reivew Article

Mar 31, 2023

Solitary Brain Metastasis Detected 1 Year After Robot-Assisted Laparoscopic Radical Nephrectomy: A Case Report  (2,112 times)
Ji Kang Yun, Woong Bin Kim, Si Hyun Kim, et al.
Korean J Urol Oncol. 2022;20(1):63-68.

Case Report

Feb 24, 2022

Current Trends in Liquid Biopsy Technology for Early Diagnosis of Metastatic Renal Cell Carcinoma  (2,097 times)
Jeong Yoon Suh, Se Jung Maeng, Mirinae Kim, et al.
Korean J Urol Oncol. 2022;20(4):223-234.

Review Article

Nov 30, 2022

Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up  (2,065 times)
Dong Gyun Kim, Ji Eun Heo, Kang Su Cho, et al.
J Urol Oncol. 2023;21(1):70-78.

Original Article

Mar 31, 2023

Delaying a Biopsy With Serial Prostate-Specific Antigen Checkup Helps to Identify a Significant Prostate Cancer: A Strategy to Evade Unnecessary Procedures  (2,043 times)
Young Hwii Ko, Byung-Hoon Kim, Wonho Jung, et al.
Korean J Urol Oncol. 2022;20(3):177-185.

Original Article

Aug 25, 2022

Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades  (2,041 times)
Sang Heon Han, Hyeong Dong Yuk
J Urol Oncol. 2023;21(1):32-44.

Original Article

Mar 31, 2023

The Landscape of Epidemiology in Urologic Cancers
Inflammatory Myofibroblastic Tumor of the Urinary Bladder in a Young Patient With Gross Hematuria: A Case Report  (2,037 times)
Han Kyu Chae, Wook Nam, Sung Jin Kim, et al.
Korean J Urol Oncol. 2022;20(1):59-62.

Case Report

Feb 24, 2022

De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor With Upper Urinary Tract Carcinoma Who Underwent Radical Nephroureterectomy and Adjuvant Chemotherapy  (2,023 times)
Jee Hwan Yoon, Chang Wook Jeong, Cheol Kwak, et al.
Korean J Urol Oncol. 2022;20(1):34-42.

Original Article

Feb 24, 2022

Peripheral T-Cell Lymphoma of Urinary Bladder Presenting With Just Irritative Voiding Symptoms  (2,003 times)
Byung Hoon Kim
Korean J Urol Oncol. 2022;20(2):133-137.

Case Report

May 26, 2022

The Current State and Future of Plasma Cell-Free DNA Analysis in Urologic Malignancies  (1,969 times)
Shusuke Akamatsu, Kei Mizuno, Takayuki Sumiyoshi, et al.
J Urol Oncol. 2023;21(1):23-31.

Reivew Article

Mar 31, 2023

Characteristics of Patients Who Visit Urologic Outpatient Department via Health Promotion Center  (1,885 times)
Jong Cheol Ko, Kwang Suk Lee, Jeong Woo Yoo
Korean J Urol Oncol. 2022;20(3):197-205.

Original Article

Aug 25, 2022

The Prognostic Impact of Angiolymphatic Invasion in Bladder Urothelial Carcinoma Patients Undergoing Radical Cystectomy  (1,851 times)
Jin Hyuck Kim, Young Hwii Ko, Jong Wook Kim, et al.
J Urol Oncol. 2023;21(1):79-87.

Original Article

Mar 31, 2023

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043


Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com

Copyright © The Korean Urological Oncology Society.

Developed in M2PI